Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000176

Chief Medical Officer sold 2,337 shares at $22.89 ($53,494)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2024-08-13 Sale −2,337 $22.89 $53,494 141,268 D
Open-market sales · 2,337 sh · avg $22.89 · $53,494
Loading xslF345X05/wk-form4_1723752552.xml…